AI assistant
SERA PROGNOSTICS, INC. — Director's Dealing 2021
Jul 15, 2021
34084_dirs_2021-07-14_3ddedf57-7662-4c61-b56c-88f507359f16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SERA PROGNOSTICS, INC. (SERA)
CIK: 0001534969
Period of Report: 2021-07-14
Reporting Person: Fisher Douglas (Chief Business Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 206132 | Direct |
| Class A Common Stock | 14430 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.73 | 2022-03-14 | Class A Common Stock (24290) | Direct | |
| Stock Option (right to buy) | $1.98 | 2027-05-18 | Class A Common Stock (93388) | Direct | |
| Stock Option (right to buy) | $1.77 | 2030-02-27 | Class A Common Stock (116161) | Direct | |
| Stock Option (right to buy) | $5.32 | 2031-03-08 | Class A Common Stock (70911) | Direct |
Footnotes
F1: Dr. Fisher is a Trustee of the Fisher 2015 Children's Irrevocable Trust. Dr. Fisher, in such capacity, may be deemed to indriectly beneficially own the securities owned by the trust except to the extent of his pecuniary interest therein, if any.
F2: These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date
and 1/36 of the original grant amount vests in monthly installments for three years following the grant date.
F3: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the grant
date.